0

Women Health Diagnostics Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21294

Download Sample Report download
Buy the Full ReportStarting from $3500
Published on

July 2021

Total pages

162

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3500

About the Report

About the Report

Women are more susceptible to certain diseases such as menstrual disorders, cancer, osteoporosis, sexual disorders, and autoimmune diseases. The major diseases include cervical cancer, breast cancer, infertility, menopause, and polycystic ovarian syndrome (PCOS). As per the Centers for Disease Control and Prevention, PCOS is one of the most common causes of female infertility, affecting 6% to 12% (as many as 5 million) of US women of reproductive age.

The demand for Women's Health Diagnostics is mainly increasing on account of the increasing incidence of chronic and lifestyle disorders, rising awareness regarding various health-related disorders, high prevalence of infectious diseases such as hepatitis and HIV in women all over the world. Moreover, the rising number of diagnostic and imaging centers and the high adoption of POC diagnostic testing also propel market growth. As per the Joint United Nations Programme on HIV and AIDS 2020, women and girls accounted for about 50% of all new HIV infections in 2020 while in sub-Saharan Africa, women and girls accounted for 63% of all new HIV infections.

However, some of the restraints in the market include inadequate reimbursements for diagnostic tests, lack of skilled laboratory technicians, and high cost of diagnostic procedures, devices.

Based on Applications, the market is fragmented into Breast Cancer Testing, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, and Prenatal Testing. Breast Cancer Testing holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to increasing breast cancer cases and rising awareness about advanced breast cancer diagnostic techniques, such as Automated Breast Ultrasonography (ABUS) which allows three-dimensional representation of breast tissue and allows images reformatting in 3D. Moreover, women suffering from breast cancer are more prone to getting affected by the COVID-19 infection. As per breastcancer.org, approximately 281,550 new cases of invasive breast cancer and 49,290 new cases of non-invasive (in situ) breast cancer are estimated to be diagnosed in women in the U.S. in 2021.

Based on End-user, the market is fragmented into Diagnostics Centers, Hospitals, and Homecare. The home care segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period due to the rising incidents of infectious diseases which has resulted in increased use of self-testing kits. The self-testing kits allow the patients to manage their diseases by utilizing these kits. Furthermore, Technological advancements have made many self-testing kits available for various conditions, such as pregnancy and ovulation. For instance, the Prega News Pregnancy Kit developed by Mankind Pharmaceuticals Ltd uses a sera reagent that will detect Human chorionic gonadotropin (HCG) content in a woman's urine, signifying whether a woman is pregnant or not remotely.

For a better understanding of the market adoption of Women Health Diagnostics, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Women Health Diagnostics market on account of the rising prevalence of infectious diseases amongst women, increasing adoption of technologically advanced products, and rising government initiatives. In 2021, Hologic, Inc., a global leader in women's health, acquired Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately USD 230 million, to strengthen its presence in the women's health diagnostics market. Some of the major players operating in the market include Abbott Laboratories, Becton, Dickinson, and Company, Biomerieux SA, Carestream Health, Hoffmann-La Roche AG, GE Healthcare, Hologic, Inc., Koninklijke Philips N.V., Mankind Pharma, and Siemens AG . Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Products


Companies

Abbott Laboratories, Becton, Dickinson, and Company, Biomerieux SA, Carestream Health, Hoffmann-La Roche AG, GE Healthcare, Hologic, Inc., Koninklijke Philips N.V., Mankind Pharma, and Siemens AG

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Objective of the Study

1.3. Limitation

1.4. Stake Holders

1.5. Currency Used in Report

1.6. Scope of the Global Women Health Diagnostics Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Methodology for the Global Women Health Diagnostics Market

2.1.1. Main Objective of the Global Women Health Diagnostics Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET REVENUE (USD BN), 2019-2027F

6 MARKET INSIGHTS BY APPLICATION

6.1. Breast Cancer Testing

6.2. Infectious Disease Testing

6.3. Osteoporosis Testing

6.4. Pregnancy and Fertility Testing

6.5. Prenatal Testing

7 MARKET INSIGHTS BY END-USER

7.1. Diagnostics Centers

7.2. Hospitals

7.3. Homecare

8 MARKET INSIGHTS BY REGION

8.1. North America Women Health Diagnostics Market

8.1.1. United States

8.1.2. Canada

8.1.3. Rest of North America

8.2. Europe Women Health Diagnostics Market

8.2.1. Germany

8.2.2. France

8.2.3. United Kingdom

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia Pacific Women Health Diagnostics Market

8.3.1. China

8.3.2. Japan

8.3.3. India

8.3.4. Australia

8.3.5. Rest of Asia Pacific

8.4. Rest of the World Women Health Diagnostics Market

9 DEMAND AND SUPPLY SIDE ANALYSIS

9.1. Demand Side Analysis

9.2. Supply Side Analysis

9.2.1. Top Product Launches

9.2.2. Top Business Partnerships

9.2.3. Top Business Expansions, Investments and Divestitures

9.2.4. Top Merger and Acquisitions

10 VALUE CHAIN ANALYSIS

11 GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET TRENDS & INSIGHTS

12 GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET DYNAMICS

12.1. Market Drivers

12.2. Market Challenges

12.3. Impact Analysis

13 GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET OPPORTUNITIES

14 COMPETITIVE SCENARIO

14.1. Porter's Five Forces Analysis

14.1.1. Bargaining power of Supplier

14.1.2. Bargaining power of Buyer

14.1.3. Industry Rivalry

14.1.4. Availability of Substitute

14.1.5. Threat of new Entrants

15 COMPANY PROFILED

15.1. Abbott Laboratories

15.2. Becton, Dickinson and Company

15.3. Biomerieux SA

15.4. Carestream Health

15.5. Hoffmann-La Roche AG

15.6. GE Healthcare

15.7. Hologic, Inc.

15.8. Koninklijke Philips N.V.

15.9. Mankind Pharma

15.10. Siemens AG

16 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022